课题基金 / 基金详情

New candidate vaccines to prevent tuberculosis: preclinical assessment of efficacy, safety and mechanism of protection

New candidate vaccines to prevent tuberculosis: preclinical assessment of efficacy, safety and mechanism of protection
预防结核病的新候选疫苗:功效、安全性和保护机制的临床前评估
批准号:
nhmrc : 1043519
负责人:
A/Pr James Triccas
金额:
$39.62万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2013
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2013-01-01 至 2016-12-31

项目摘要

项目成果

A/Pr James Triccas的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Almost two million people die from tuberculosis (TB) each year. The curent vaccine, BCG, is ineffective at controlling TB and and the type of immune response needed to protect against the disease is poorly understood. We have discovered new antigens of the TB bacterium, and we will combine them with our innovative vaccine technology to develop new vaccines to control TB. We will also try and understand why BCG is not effective, and use this information to further improve TB vaccination.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multistage vaccines for the prevention of tuberculosis
  • 批准号:
    nhmrc : 1102597
  • 项目类别:
    Project Grants
  • 资助金额:
    $60.84万
  • 财政年份:
    2016
  • 负责人:
    A/Pr James Triccas
  • 依托单位:
A new class of inhibitors for the treatment of tuberculosis
  • 批准号:
    nhmrc : 1084266
  • 项目类别:
    Project Grants
  • 资助金额:
    $48.06万
  • 财政年份:
    2015
  • 负责人:
    A/Pr James Triccas
  • 依托单位:
Genes of Mycobacterium tuberculosis essential for Latent Tuberculosis Infection
  • 批准号:
    nhmrc : 1051246
  • 项目类别:
    Project Grants
  • 资助金额:
    $39.35万
  • 财政年份:
    2013
  • 负责人:
    A/Pr James Triccas
  • 依托单位:
Tuberculosis control:from discovery to public health practice and policy
  • 批准号:
    nhmrc : 1043225
  • 项目类别:
    Centres of Research Excellence
  • 资助金额:
    $174.14万
  • 财政年份:
    2012
  • 负责人:
    A/Pr James Triccas
  • 依托单位:
国内基金
海外基金
短QT综合征新致病基因的定位研究
  • 批准号:
    30771183
  • 项目类别:
    面上项目
  • 资助金额:
    8.0万元
  • 批准年份:
    2007
  • 负责人:
    吕利雄
  • 依托单位: